Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

A L Baltch

Showing results (21-30 of 89) with videos related to

Pageof 9
Sort By:
The Journal of Antimicrobial Chemotherapy|June 1, 1991
Comparative in-vitro susceptibilities of Pseudomonas aeruginosa, Xanthomonas maltophilia, and Pseudomonas spp. to sparfloxacin (CI-978, AT-4140, PD131501) and reference antimicrobial agentsA Louie, A L Baltch, W J Ritz, et al.
Antimicrobial Agents and Chemotherapy|October 3, 1998
Comparison of inhibitory and bactericidal activities and postantibiotic effects of LY333328 and ampicillin used singly and in combination against vancomycin-resistant Enterococcus faeciumA L Baltch, R P Smith, W J Ritz, et al.
Antimicrobial Agents and Chemotherapy|September 1, 1988
In vitro activities of PD 117,596 and reference antibiotics against 448 clinical bacterial strainsR P Smith, A L Baltch, M C Hammer, et al.
Clinical Therapeutics|January 1, 1986
In vitro activity of CI-934 and other antimicrobial agents against gram-positive and gram-negative bacteriaR P Smith, A L Baltch, M C Hammer, et al.
Chemotherapy|June 16, 2001
Inhibitory and bactericidal effects of telithromycin (HMR 3647, RU 56647) and five comparative antibiotics, used singly and in combination, against vancomycin-resistant and vancomycin-susceptible enterococciA L Baltch, R P Smith, W J Ritz, et al.
Cryobiology|December 1, 1986
Effects of storage and incubation conditions on human granulocyte phagocytic, bactericidal, and chemotactic functionsM C Hammer, A L Baltch, J V Conroy, et al.
Antimicrobial Agents and Chemotherapy|December 3, 1998
Antibacterial effects of levofloxacin, erythromycin, and rifampin in a human monocyte system against Legionella pneumophilaA L Baltch, R P Smith, M A Franke, et al.
Antimicrobial Agents and Chemotherapy|September 1, 1984
Comparative in vitro activities of enoxacin (CI-919, AT-2266) and eleven antipseudomonal agents against aminoglycoside-susceptible and -resistant Pseudomonas aeruginosa strainsC M Bassey, A L Baltch, R P Smith, et al.
Antimicrobial Agents and Chemotherapy|October 1, 1984
Effect of aztreonam in combination with azlocillin or piperacillin on Pseudomonas aeruginosaD H Wu, A L Baltch, R P Smith, et al.
Clinical Therapeutics|January 1, 1984
Inhibitory and bactericidal activities of amifloxacin, a new quinolone carboxylic acid, compared with those of seven other antimicrobial agentsA L Baltch, N T Sutphen, R P Smith, et al.
Pageof 9

Showing results (21-30 of 89) with videos related to

Sort By:
Pageof 9
The Journal of Antimicrobial Chemotherapy|June 1, 1991
Comparative in-vitro susceptibilities of Pseudomonas aeruginosa, Xanthomonas maltophilia, and Pseudomonas spp. to sparfloxacin (CI-978, AT-4140, PD131501) and reference antimicrobial agentsA Louie, A L Baltch, W J Ritz, et al.
Antimicrobial Agents and Chemotherapy|October 3, 1998
Comparison of inhibitory and bactericidal activities and postantibiotic effects of LY333328 and ampicillin used singly and in combination against vancomycin-resistant Enterococcus faeciumA L Baltch, R P Smith, W J Ritz, et al.
Antimicrobial Agents and Chemotherapy|September 1, 1988
In vitro activities of PD 117,596 and reference antibiotics against 448 clinical bacterial strainsR P Smith, A L Baltch, M C Hammer, et al.
Clinical Therapeutics|January 1, 1986
In vitro activity of CI-934 and other antimicrobial agents against gram-positive and gram-negative bacteriaR P Smith, A L Baltch, M C Hammer, et al.
Chemotherapy|June 16, 2001
Inhibitory and bactericidal effects of telithromycin (HMR 3647, RU 56647) and five comparative antibiotics, used singly and in combination, against vancomycin-resistant and vancomycin-susceptible enterococciA L Baltch, R P Smith, W J Ritz, et al.
Cryobiology|December 1, 1986
Effects of storage and incubation conditions on human granulocyte phagocytic, bactericidal, and chemotactic functionsM C Hammer, A L Baltch, J V Conroy, et al.
Antimicrobial Agents and Chemotherapy|December 3, 1998
Antibacterial effects of levofloxacin, erythromycin, and rifampin in a human monocyte system against Legionella pneumophilaA L Baltch, R P Smith, M A Franke, et al.
Antimicrobial Agents and Chemotherapy|September 1, 1984
Comparative in vitro activities of enoxacin (CI-919, AT-2266) and eleven antipseudomonal agents against aminoglycoside-susceptible and -resistant Pseudomonas aeruginosa strainsC M Bassey, A L Baltch, R P Smith, et al.
Antimicrobial Agents and Chemotherapy|October 1, 1984
Effect of aztreonam in combination with azlocillin or piperacillin on Pseudomonas aeruginosaD H Wu, A L Baltch, R P Smith, et al.
Clinical Therapeutics|January 1, 1984
Inhibitory and bactericidal activities of amifloxacin, a new quinolone carboxylic acid, compared with those of seven other antimicrobial agentsA L Baltch, N T Sutphen, R P Smith, et al.
Pageof 9